At the recent Digital Biomarkers and Clinical Measures in Neurology meeting, Koneksa was honored to speak on the importance of digital biomarkers to research into central nervous system (CNS) conditions,…
Read More
The digital field has been greatly transformed during the 18 months of the pandemic. The timid pre-pandemic attempts to test and explore digital health technologies (DHT) were swiftly replaced by…
NEW YORK – November 3, 2021 – Koneksa, the leader in developing and implementing patient-centric digital biomarkers for drug development, today announced that Sanofi, one of the world’s top biopharmaceutical...
Read More
The International Society for CNS Clinical Trials and Methodology (ISCTM) is a multi-disciplinary independent organization devoted to promoting advances in clinical research methods and addressing strategic clinical, regulatory, methodological, and…
